New Positive Pre-clinical Data for Active Biotech AB’s RA Project I- 3D

LUND, SWEDEN--(MARKET WIRE)--Jun 15, 2007 -- Active Biotech (OMX Nordic: ACTI) presented pre-clinical results for the project I-3D at the annual EULAR (The European League Against Rheumatism, www.eular.org ) conference, June 13-16*.